{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+%28Oral%29&page=3", "query": { "intervention": "Alcohol (Oral)", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 742, "total_pages": 75, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+%28Oral%29&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+%28Oral%29&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T10:38:02.316Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01227980", "title": "Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol-Related Disorders", "Alcohol Dependence", "Alcoholism", "Anxiety Disorder" ], "interventions": [ { "name": "Pexacerfont", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 70, "start_date": "2010-10", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2016-02-02", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01227980" }, { "nct_id": "NCT00993421", "title": "A Weight Loss Study in Overweight Men and Women", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "LY377604", "type": "DRUG" }, { "name": "Sibutramine", "type": "DRUG" }, { "name": "Metoprolol", "type": "DRUG" }, { "name": "Placebo sibutramine", "type": "DRUG" }, { "name": "Placebo Metoprolol", "type": "DRUG" }, { "name": "Placebo LY377604", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 343, "start_date": "2009-10", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2011-06-03", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 21, "location_summary": "Mesa, Arizona • Concord, California • La Jolla, California + 18 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00993421" }, { "nct_id": "NCT02103998", "title": "Study of Thyroid Hormones in Prematures", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Transient Hypothyroxinemia of Prematurity (THOP)" ], "interventions": [ { "name": "thryoid hormone T4 + oral potassium iodide (KI) for 42 days", "type": "DRUG" }, { "name": "D5W - 5% dextrose water", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York Medical College", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Hour", "maximum_age": "24 Hours", "sex": "ALL", "summary": "1 Hour to 24 Hours" }, "enrollment_count": 0, "start_date": "2020-07-01", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Valhalla, New York", "locations": [ { "city": "Valhalla", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02103998" }, { "nct_id": "NCT03904849", "title": "Cannabidiol for Alcohol Use Disorder", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "Cannabidiol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "21 Years to 40 Years" }, "enrollment_count": 0, "start_date": "2019-10-01", "completion_date": "2020-04-30", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03904849" }, { "nct_id": "NCT01043640", "title": "Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mucopolysaccharidosis", "Hurler Syndrome", "Hunter Syndrome", "Maroteaux-Lamy Syndrome", "Sly Syndrome", "Alpha Mannosidosis", "Fucosidosis", "Aspartylglucosaminuria", "Adrenoleukodystrophy (ALD)", "Krabbe Disease", "Metachromatic Leukodystrophy (MLD)", "Sphingolipidoses", "Peroxisomal Disorders" ], "interventions": [ { "name": "Campath-1H", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Allogeneic stem cell transplantation", "type": "PROCEDURE" }, { "name": "Cyclosporine A", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 46, "start_date": "2009-12", "completion_date": "2017-06", "has_results": true, "last_update_posted_date": "2018-02-05", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01043640" }, { "nct_id": "NCT01431326", "title": "Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenovirus", "Anesthesia", "Anxiety", "Anxiolysis", "Autism", "Autistic Disorder", "Bacterial Meningitis", "Bacterial Septicemia", "Benzodiazepine", "Bipolar Disorder", "Bone and Joint Infections", "Central Nervous System Infections", "Convulsions", "Cytomegalovirus Retinitis", "Early-onset Schizophrenia Spectrum Disorders", "Epilepsy", "General Anesthesia", "Gynecologic Infections", "Herpes Simplex Virus", "Infantile Hemangioma", "Infection", "Inflammation", "Inflammatory Conditions", "Intra-abdominal Infections", "Lower Respiratory Tract Infections", "Migraines", "Pain", "Pneumonia", "Schizophrenia", "Sedation", "Seizures", "Skeletal Muscle Spasms", "Skin and Skin-structure Infections", "Treatment-resistant Schizophrenia", "Urinary Tract Infections", "Withdrawal", "Sepsis", "Gram-negative Infection", "Bradycardia", "Cardiac Arrest", "Cardiac Arrhythmia", "Staphylococcal Infections", "Nosocomial Pneumonia", "Neuromuscular Blockade", "Methicillin Resistant Staphylococcus Aureus", "Endocarditis", "Neutropenia", "Headache", "Fibrinolytic Bleeding", "Pulmonary Arterial Hypertension", "CMV Retinitis", "Hypertension", "Chronic Kidney Diseases", "Hyperaldosteronism", "Hypokalemia", "Heart Failure", "Hemophilia", "Heavy Menstrual Bleeding", "Insomnia" ], "interventions": [ { "name": "The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daniel Benjamin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 3520, "start_date": "2011-11", "completion_date": "2019-11", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 43, "location_summary": "Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431326" }, { "nct_id": "NCT00939120", "title": "Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Benign Prostatic Hyperplasia (BPH)" ], "interventions": [ { "name": "Tolterodine ER 4mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Pre-randomization Dutasteride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Siami, Paul F., M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "MALE", "summary": "50 Years and older · Male only" }, "enrollment_count": 46, "start_date": "2009-07", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2015-05-01", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Newburgh, Indiana", "locations": [ { "city": "Newburgh", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00939120" }, { "nct_id": "NCT02544763", "title": "A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberous Sclerosis Complex", "Seizures" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "65 Years", "sex": "ALL", "summary": "1 Year to 65 Years" }, "enrollment_count": 224, "start_date": "2016-04-06", "completion_date": "2019-02-26", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02544763" }, { "nct_id": "NCT05551104", "title": "Safest Choice of Antihypertensive Regimen for Postpartum Hypertension", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postpartum Complication", "Maternal Hypertension", "High Blood Pressure" ], "interventions": [ { "name": "Oral Nifedipine", "type": "DRUG" }, { "name": "Oral Labetalol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 500, "start_date": "2023-05-08", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05551104" }, { "nct_id": "NCT02138747", "title": "A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Overactive Bladder (OAB)" ], "interventions": [ { "name": "Mirabegron", "type": "DRUG" }, { "name": "Tolterodine ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 376, "start_date": "2014-07-24", "completion_date": "2015-11-11", "has_results": true, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-10-06T10:38:02.316Z", "location_count": 22, "location_summary": "Homewood, Alabama • Anchorage, Alaska • Tucson, Arizona + 19 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Sherman Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02138747" } ] }